Investor Brief · October 2026

Korean hospitals,
opened to the world.

DoctorKit is the AI medical network connecting Korean hospitals with global patients — from hospital search and booking to the operating room and follow-up care.

Live on iOS & Android in every country

Mediyo patient app — home screen with live interpretation entry
Real-time medical interpretation between English and Korean
Live interpretation

🇺🇸 “When did you start having a fever?”

🇰🇷 “어제부터 열이 있었습니다.”

70+
Hospitals in pipeline
40+
Under preliminary agreement
2026.09
Live on iOS & Android, all countries
2026.11
Billing & subscription go-live

The bottleneck

Bringing patients in was never the problem.

Foreign-patient acquisition doesn't break at sourcing. It breaks at the point of care — in the ten minutes where a doctor and a patient have to understand each other.

“A Vietnamese patient was already on the eye-surgery table. The interpreter never showed up — the surgery was cancelled and the patient was sent home.”

If a hospital cannot treat the patients it receives, neither the revenue nor the reputation stays.

Before

We focused on sourcing

Patients were sent to hospitals, but visits didn't convert into treatment.

Insight

Interpretation comes first

And it has to sit inside the hospital's workflow — not in a call center outside it.

Shift

We built the product instead

We stopped recruiting and started building. Live on iOS and Android in every country as of September 2026.

The product

One network, three surfaces.

A patient app, a hospital platform, and the medical interpretation that ties them together.

Interpretation

It keeps working where translation apps stop.

Doctor and patient speak their own language on their own device. The translation appears as they talk — hands-free, through earphones, tuned for medical conversation rather than small talk.

  • Doctor and patient on separate devices, hands-free with earphones
  • Tuned for medical conversation — not everyday chat
  • Designed to be used during treatment and in the operating room
Real-time medical interpretation between English and Korean
A two-sided screen: each person reads the conversation in their own language, on their own side of the phone.

Mediyo · patient app

Everything before and after the visit.

Patients find a hospital, ask questions in their own language, book, pay, and keep talking to the hospital after they fly home — all in one app.

  • Multilingual hospital search and booking
  • Per-hospital AI that answers in the patient's language
  • Video consultation, AI intake and follow-up after returning home
Mediyo patient app home screen

DoctorKit · hospital platform

The hospital side, in one system.

Branch-level operations, role-based access, a chatbot that answers only from that hospital's own data, and usage-based billing.

  • Branch management with per-branch data isolation
  • A chatbot that answers only from the hospital's own data
  • Usage-based billing infrastructure, launching November 2026
DoctorKit hospital platform with a video consultation

The network

Two brands, one network.

DoctorKit sells to hospitals. Mediyo brings the patients. The AI connects them — and both ends of the network pay.

DoctorKit
builds the infrastructure

The hospital platform: interpretation, intake, per-hospital AI and billing.

Mediyo
brings the patients

The patient app: search, booking, payment and care in their own language.

AI
connects them

Medical interpretation that runs through the whole journey, including the operating room.

Traction & go-to-market

The hospitals are already there.

This isn't a cold start. We hold hospitals and clinics we can contract with today, through a sales line that already calls on them.

70+
Hospitals in pipeline
40+
Hospitals under preliminary agreement
2026.10
Hospital beta
2026.11
Billing & subscription go-live

A sales line that already covers the market

Our CTO has been running Korea's largest dental-industry business together with a global pharmaceutical company since 2017. The CTO and CBO personally know the sales representatives who cover that market.

Partner hospitals

Logos of DoctorKit partner hospitals and clinics

Global expansion

From Korean hospitals to global patient demand.

Starting with the Middle East and the United States, where the network already exists.

Overseas hospitals & medical tourism

Middle East (Kuwait · Saudi Arabia) · United States · Canada · Southeast Asia · Europe

  • Local hospital and health-authority networks
  • Hospital-group contracts and local partners

Government programs · KHIDI 2027

A consortium joined by partner hospitals under Korea's overseas-expansion program.

  • Overseas hospital establishment and entrusted operations
  • Medical-system export with partner hospitals

Overseas Koreans & international organizations

Trust and reach beyond the medical-tourism market.

  • Overseas Koreans Agency, Korean associations and chambers of commerce
  • Working with embassies and international organizations

Arabic medical interpretation already works. Combined with 40 years of on-the-ground network in Kuwait, the Middle East is a same-day market for us.

Team

People who have done this their whole lives.

Global patient sourcing, Korean pharma and hospital sales, AI engineering, and medical leadership — in one room.

  • Daeho Kim

    CEO & Co-founder

    Patient demand · Global

    15+ years in foreign-patient sourcing. 40 years based in Kuwait. Trading with top-tier Korean hospitals, including CHAUM.

  • Jongkwan Park

    Founder & CTO

    Technology · Platform

    25 years in AI and technology. Has run Korea's largest dental-industry business with a global pharmaceutical company since 2017. Built the multilingual medical interpretation stack.

  • Sangtae Kim

    CBO

    Hospital supply · Korea

    25 years in business development at Eli Lilly, Zuellig Pharma and Zimmer Biomet, where he led sales.

  • Yongbae Kim

    CSO

    Sales & organization

    30 years in sales, HR and organization. Former Vice President of Lilly Korea and a sales-strategy specialist.

  • Sera Lee

    Director

    Medical leadership

    Physician and former Vice Chairman of the Seoul Medical Association. Led its at-home treatment support center during COVID-19.

Questions

What investors ask us.

Why won't hospitals just use a translator or an agency?

Agencies need lead time and can't be in the room during treatment. General translation apps are built for everyday conversation and stop working when the setting becomes clinical. Our interpretation runs on the doctor's and the patient's own devices, hands-free, and is designed to be used during treatment.

What do hospitals actually pay for?

A monthly per-branch subscription that includes the foreign patients they already have, plus a commission on patients we source for them. Billing and subscription go live in November 2026, following the October hospital beta.

How do you get hospitals at this stage?

Through a sales line we already run. Our CTO has been operating Korea's largest dental-industry business with a global pharmaceutical company since 2017, and the CTO and CBO personally know the representatives who cover that market.

Where does the patient demand come from?

Two places. Our CEO has spent 15+ years sourcing foreign patients, with a base in Kuwait and a network across the Middle East and the Americas. On top of that, Mediyo is a live consumer app in every country, which builds demand directly.

How is patient data handled?

Medical data is encrypted in transit and at rest, access is role-based and audited, and each hospital's data is isolated from every other hospital's. Personal information is anonymized before it reaches AI processing.

What does the raise fund?

The next 12 months of hospital rollout in Korea, the billing and subscription launch, and the first overseas expansion — starting with the Middle East, where our network and Arabic interpretation are already in place. Full figures are in the deck.

Contact

Let's talk.

For the full deck, financials and a product demo, reach out — we reply directly.

This page is provided for information only and does not constitute an offer to sell, or a solicitation of an offer to buy, any securities.